InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Cotliar Jonathan, Directeur Médical. Director active across 1 company, notably Science 37 Holdings, Inc.. Cumulatively, 6 reports have been recorded. Activity tracked since 25 October 2021. The latest transaction was filed on 12 March 2024 (U). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Cotliar Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
41,891 股@ US$5.7597.2% 占其流量Common StockSEC:0001819113-24-000023:0
230,882 股0Common StockSEC:0001819113-23-000069:0
257,320 股Common StockSEC:0001819113-23-000036:0
3,905 股@ US$0.851.3% 占其流量Common StockSEC:0001819113-22-000016:0
4,538 股@ US$0.851.5% 占其流量Common StockSEC:0001104659-22-027327:0
533,264 股Common StockSEC:0001104659-21-124839:0
6 条申报中的 6 条
About Cotliar Jonathan
Jonathan Cotliar is the Chief Medical Officer of Science 37 Holdings, Inc. In this role, he oversees the medical and clinical aspects of the company's projects, ensuring that research initiatives comply with industry standards. His expertise is essential for the development of new treatments.
